Other Events ·
Profound Medical Corp. announced the introduction of its new real-time interventional MRI Software, specifically the…
PROFProfound Medical Corp.
Profound Medical Corp. announced the introduction of its new real-time interventional MRI Software, specifically the latest Treatment Delivery Consol (TDC) software, on August 17, 2026. This update is being deployed across the installed base of TULSA-PRO systems to increase procedural efficiency and reduce planning complexity. The company states that physicians report performing up to four procedures per day with current capabilities, while the new software aims to support a roadmap for achieving up to six procedures daily. Profound Medical Corp. operates in the medical device industry, developing and marketing interventional MRI procedures such as TULSA-PRO for prostate ablation and Sonalleve for non-surgical therapy.